Back to video list Back to Home Which patients should receive a monoclonal antibody for migraine prevention and the implications of medication overuse You may also like Depression Article Major Depressive Disorder and Physical Health: Mind-body Connection Schizophrenia Congress highlights Article Do clinicians need to rethink antipsychotic maintenance treatment? Schizophrenia Congress highlights Article Are prior mood disorders more important than positive symptoms for predicting psychosis? Schizophrenia Article Acceptability of Long-acting Injectables (LAIs) for Schizophrenia Treatment in Taiwan